BioGaia AB (publ) (STO: BIOG-B) Stock Analysis & Fundamentals

BIOG-BBioGaia AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · biogaiagroup.com

115.50SEK+0.70%Mkt Cap: 1.11B $P/E: 33.44Today

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, a…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap1.11B $

Enterprise Value1.07B $

Revenue (TTM)151.19M $

Gross Profit107.95M $

Net Income (TTM)31.83M $

Revenue/Share1.495 USD

Last Price115.50 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees251

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)33.44

P/E (Forward)26.63

PEG—

EV/EBITDA24.54

EV/Revenue7.06

P/S7.38

P/B10.59

EPS (TTM)3.43

EPS (Forward)4.33

52W Range

93.4052% of range136.30

52W High136.30 SEK

52W Low93.40 SEK

Profitability

Gross Margin73.37%

Oper. Margin28.39%

EBITDA Margin28.76%

Profit Margin21.63%

ROE25.32%

ROA20.83%

Growth

Revenue Growth8.90%

Earnings Growth17.40%

Cash Flow & Leverage

Operating CF29.32M $

CapEx (TTM)344.25K $

FCF Margin14.46%

FCF Yield1.97%

Net Debt-42.69M $

Net Debt/EBITDA-0.98

Balance Sheet

Debt/Equity—

Current Ratio4.44

Quick Ratio2.11

Book Value/Sh10.88 SEK

Cash/Share4.411 SEK

Dividends

Fwd Div Rate1.640 SEK

Trail. Div Rate1.640 SEK

Div. Yield1.43%

5Y Avg Yield1.29%

Payout Ratio47.81%

Ex-Div DateMay 8, 2026

Pay Date—

Splits

Last Split5:1

Split DateMay 18, 2022

Analyst Consensus

Rating—

Target (Mean)152.50 SEK

Upside (mean)+32.0%

Target Range140.00 SEK – 165.00 SEK

SEK140.00+32.0% to meanSEK165.00

# Analysts2

Ownership

Shares Out.98.50M

Float83.94M

Insiders17.00%

Institutions53.23%

Technical

SMA 50117.08 (-1.3%)

SMA 200113.53 (+1.7%)

Beta0.32

S&P 52W Chg18.16%

Avg Vol (30d)137.25K

Avg Vol (10d)145.56K

Technical Indicators

RSI (14)47.4

MACD-1.2652

MACD Signal-1.5653

MACD Hist.+0.3001

BB Upper119.53 SEK

BB Middle114.86 SEK

BB Lower110.19 SEK

BB Width8.13%

ATR (14)2.776 SEK

Vol Ratio (20d)1.18x